Wed 25 Nov 2009 | 10:19 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc. (CYCC.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Biotechnology · View CYCC on other exchanges

As of 9:45am EST

0.83USD

Price Change

+0.01

Percent Change

+1.22%

Analyst Recommendations

Independent Research | Broker Research

Name	Age	Since	Current Position
Sosnowski, Robert	50	2008	Vice President - Sales & Marketing
Chiao, Judy	49	2006	Vice President - Clinical Development and Regulatory Affairs
Rombotis, Spiro	50	2006	President, Chief Executive Officer, Director
Henney, Christopher	68	2006	Director
Spiegelman, Daniel	50	2004	Director
Banham, John	68	2006	Director
Bacopoulos, Nicholas	60	2008	Director
McBarron, Paul	48	2006	Chief Operating Officer, Executive Vice President - Finance, Secretary, Director
U'Prichard, David	60	2006	Chairman of the Board

Find out more about CYCC.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.